NLM Logo

sofosbuvir-velpatasvir drug combination MeSH Supplementary Concept Data 2025


MeSH Supplementary
sofosbuvir-velpatasvir drug combination
Unique ID
C000611331
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000611331
Entry Term(s)
Epclusa
sofosbuvir velpatasvir drug combination
sofosbuvir, velpatasvir drug combination
Pharm Action
Antiviral Agents
Registry Numbers
0
Heading Mapped to
*Carbamates
*Drug Combinations
*Heterocyclic Compounds, 4 or More Rings
*Sofosbuvir
Frequency
69
Note
A combined pharmaceutical preparation of the antiviral agents sofosbuvir and valpatasvir that is used to treat all six major genotypes of HEPATITIS C VIRUS (HCV) infections.
Source
Med Lett Drugs Ther. 2016 Aug 15;58(1501):107-8.
Date of Entry
2016/10/26
Revision Date
2020/11/23
sofosbuvir-velpatasvir drug combination Preferred
Epclusa Narrower
page delivered in 0.005s